[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334852-105":59,"doc-detail-334852-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sirpg-expression-positively-associates-with-an-inflamed-tumor-microenvironment-and-response-to-pd-1-blockade-abstract-research-paper","SIRPG expression positively associates with an inflamed tumor microenvironment and response to PD-1 blockade - Abstract - Research paper","","Background: This study examines how signal regulatory protein gamma (SIRPG) relates to tumor immune microenvironment phenotypes and T cell–mediated adaptive antitumor immunity, and whether SIRPG can predict clinical response to PD-1 blockade. Methods: Pan-cancer transcriptomic analysis across 33 tumor types was integrated with immune deconvolution. Clinical cohorts included 157 non-small-cell lung cancer and melanoma patients treated with PD-1 blockade, and single-cell RNA-seq spanning 103,599 cells was used to characterize SIRPG expression. Functional validation used SIRPG knockdown or overexpression in Jurkat T cells. Results: High SIRPG expression correlated with increased T cells, B cells, NK cells, M1 macrophages, cytotoxic lymphocytes, and higher immune-recruitment and antigen-presentation programs, while showing reduced neutrophils, M2 macrophages, and MDSCs. In both NSCLC and melanoma, high SIRPG expression predicted favorable PD-1 blockade response; scRNA-seq indicated SIRPG enrichment in CD8+ exhausted and CD4+ regulatory T cells and linked it to immune checkpoint genes PDCD1 and CTLA4, supported by in vitro findings in T cells. Conclusion: SIRPG is associated with an inflamed immune phenotype and beneficial PD-1 blockade response, suggesting biomarker and therapeutic target potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sirpg-expression-positively-associates-with-an-inflamed-tumor-microenvironment-and-response-to-pd-1-blockade-abstract-research-paper/334852/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sirpg-expression-positively-associates-with-an-inflamed-tumor-microenvironment-and-response-to-pd-1-blockade-abstract-research-paper/334852.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about SIRPG?","Question",{"text":112,"@type":113},"The study investigates how SIRPG expression relates to tumor immune microenvironment phenotypes and T cell–mediated adaptive antitumor immunity, and whether SIRPG predicts response to PD-1 blockade.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were SIRPG and immune microenvironment relationships evaluated?",{"text":117,"@type":113},"Pan-cancer transcriptomic data with immune deconvolution was analyzed across 33 tumor types, and cohorts of 157 NSCLC and melanoma patients treated with PD-1 blockade were assessed. Single-cell RNA-seq data covering 103,599 cells were used to define expression patterns, and Jurkat T cell experiments tested SIRPG knockdown or overexpression effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings linking SIRPG to PD-1 therapy response?",{"text":121,"@type":113},"High SIRPG expression corresponded to an inflamed immune phenotype with increased immune effector cells and reduced suppressive myeloid populations, and it predicted favorable PD-1 blockade responses in both NSCLC and melanoma. Single-cell results linked SIRPG to exhausted CD8+ T cells and regulatory CD4+ T cells, with positive association to PDCD1 and CTLA4, supported by in vitro effects in T cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334852,1790187212,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":4},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Cancer Immunology, Immunotherapy (2024) 73:147 [https://doi.org/10.1007/s00262-024-03737-y](https://doi.org/10.1007/s00262-024-03737-y)  \nSIRPG expression positively associates with an inflamed tumor microenvironment and response to PD‑1 blockade  \nLibo Luo1 · Minlin Jiang1 · HongWu2 · Yiqiang Liu2 · Haowei Wang1 · Caicun Zhou1 · Shengxiang Ren1 · Xiaoxia Chen1 · Tao Jiang1 · Chuan Xu2  \nReceived: 21 March 2024 / Accepted: 15 May 2024 / Published online: 4 June 2024 © The Author(s) 2024  \nAbstract  \nBackground This study aimed to investigate the relationship between signal regulatory protein gamma (SIRPG) and tumor immune microenvironment phenotypes or T cell mediated-adaptive antitumor immunity, and its predictive value for response to PD-1 blockade in cancers.  \nMethods Pan-cancer analysis of SIRPG expression and immune deconvolution was performed using transcriptomic data across 33 tumor types. Transcriptomic and clinical data from 157 patients with non-small-cell lung cancer (NSCLC) and melanoma received PD-1 blockade were analyzed. Expression characteristics of SIRPG were investigated using single-cell RNA sequencing (scRNA-seq) data of 103,599 cells. The effect of SIRPG expression was evaluated via SIRPG knockdown or overexpression in Jurkat T cells.  \nResults The results showed that most cancers with high SIRPG expression had significantly higher abundance of T cells, B cells, NK cells, M1 macrophages and cytotoxic lymphocytes and increased expression level of immunomodulatory factors regulating immune cell recruitment, antigen presentation, T cell activation and cytotoxicity, but markedly lower abundance of neutrophils, M2 macrophages, and myeloid-derived suppressor cells. High SIRPG expression was associated with favorable response to PD-1 blockade in both NSCLC and melanoma. scRNA-seq data suggested SIRPG was mainly expressed in CD8+ exhausted T and CD4+ regulatory T cells, and positively associated with immune checkpoint expression including PDCD1 and CTLA4 . In vitro test showed SIRPG expression in T cells could facilitate expression of PDCD1 and CTLA4 . Conclusion High SIRPG expression is associated with an inflamed immune phenotype in cancers and favorable response to PD-1 blockade, suggesting it would be a promising predictive biomarker for PD-1 blockade and novel immunotherapeutic target.  \nKeywords Programmed cell death 1 receptor · PD-1 · SIRPG · Tumor microenvironment · Biomarker · Lung cancer  \nAbbreviations  \nB2M β2-Microglobulin  \nCI Confidence interval  \nLibo Luo, Minlin Jiang, Hong Wu and Yiqiang Liu have contributed equally to this work.  \n* Xiaoxia Chen [cheetos_xx@126.com](cheetos_xx@126.com)  \n* Tao Jiang [tonyjiangdr@163.com](tonyjiangdr@163.com)  \n* Chuan Xu [xuchuan100@163.com](xuchuan100@163.com)  \n1 Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute, Tongji University School of Medicine, No. 507 Zhengmin Road, Shanghai 200433, China  \nCOAD Colon adenocarcinoma  \nCR Complete response  \nDCs Dendritic cells  \nDEGs Differentially expressed genes  \nESCA Esophageal carcinoma  \n2 Department of Oncology and Cancer Institute, Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, No. 32 1st Ring Road, Chengdu 610072, China  \nFDR  \nGBM  \nGEO  \nGGN  \nHNSC  \nHR  \nKIRC  \nKIRP  \nLUAD  \nLUSC  \nMDSC  \nMHC  \nMSI  \nNSCLC  \nORR  \nOS  \nPCA  \nPD  \nPFS  \nPR  \nqRT-PCR  \nREADscRNA-seq SD SIRPG SKCM  \nSTAD  \nTCGA  \nTMB  \ntSNE  \nUCEC  \nFalse discovery rates Glioblastoma multiforme Gene expression omnibus Ground glass nodule  \nHead and neck squamous cell carcinoma Hazard ratio  \nKidney renal clear cell carcinoma Kidney renal papillary cell carcinoma Lung adenocarcinoma  \nLung squamous cell carcinoma Myeloid-derived suppressor cell Major histocompatibility complex  \nMicrosatellite instability Non-small-cell","cbCaiikEBEuL4t5u","https://ap.wps.com/l/cbCaiikEBEuL4t5u","pdf",6948086,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Abbreviations\n# Introduction","[{\"question\":\"What question does the study address about SIRPG?\",\"answer\":\"The study investigates how SIRPG expression relates to tumor immune microenvironment phenotypes and T cell–mediated adaptive antitumor immunity, and whether SIRPG predicts response to PD-1 blockade.\"},{\"question\":\"How were SIRPG and immune microenvironment relationships evaluated?\",\"answer\":\"Pan-cancer transcriptomic data with immune deconvolution was analyzed across 33 tumor types, and cohorts of 157 NSCLC and melanoma patients treated with PD-1 blockade were assessed. Single-cell RNA-seq data covering 103,599 cells were used to define expression patterns, and Jurkat T cell experiments tested SIRPG knockdown or overexpression effects.\"},{\"question\":\"What were the main findings linking SIRPG to PD-1 therapy response?\",\"answer\":\"High SIRPG expression corresponded to an inflamed immune phenotype with increased immune effector cells and reduced suppressive myeloid populations, and it predicted favorable PD-1 blockade responses in both NSCLC and melanoma. Single-cell results linked SIRPG to exhausted CD8+ T cells and regulatory CD4+ T cells, with positive association to PDCD1 and CTLA4, supported by in vitro effects in T cells.\"}]","SIRPG expression positively associates with an inflamed tumor microenvironment and response to PD-1 blockade - Abstract - Research paper | PDF",1790008594]